Non-aggregated Aβ25-35 Upregulates Primary Astrocyte Proliferation In Vitro

非聚集态Aβ25-35在体外上调原代星形胶质细胞增殖

阅读:1

Abstract

Amyloid beta (Aβ) is a peptide cleaved from amyloid precursor protein that contributes to the formation of senile plaques in Alzheimer's disease (AD). The relationship between Aβ and astrocyte proliferation in AD remains controversial. Despite pathological findings of increased astrocytic mitosis in AD brains, in vitro studies show an inhibitory effect of Aβ on astrocyte proliferation. In this study, we determined the effect of an active fragment of Aβ (Aβ(25-35)) on the cell cycle progression of primary rat astrocytes. We found that Aβ(25-35) (0.3-1.0 μg/ml) enhanced astrocyte proliferation in vitro in a time- and concentration-dependent manner. Increased DNA synthesis by Aβ(25-35) was observed during the S phase of the astrocyte cell cycle, as indicated by proliferation kinetics and bromodeoxyuridine immunocytochemical staining. Aggregation of Aβ(25-35) abolished the upregulatory effect of Aβ on astrocyte proliferation. Further examination indicated that Aβ(25-35) affected astrocyte proliferation during early or mid-G(1) phase but had no effect on DNA synthesis at the peak of S phase. These results provide insight into the relationship between Aβ(25-35) and astrocyte cell cycling in AD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。